Discovery pet ct 600
The Discovery PET/CT 600 is a medical imaging system that combines Positron Emission Tomography (PET) and Computed Tomography (CT) technologies. It is designed to acquire high-quality images for diagnostic and treatment planning purposes.
Lab products found in correlation
15 protocols using discovery pet ct 600
PET/CT Imaging of Metformin Biodistribution
PET/CT Imaging Protocol for 18F-FDG
FDG-PET Imaging for Lymph Node Assessment
Quantifying BAT Activation via FDG-PET/CT
Comparative Analysis of PET/CT Scanners
Comparison of device features
Discovery 600 | Discovery 710 | |
---|---|---|
Transaxial FOV (mm) | 700 | 700 |
Axial FOV (mm) | 157 | 157 |
No. of ring | 24 | 24 |
No. of individual crystals | 12,288 | 13,824 |
No. of crystals/ring | 512 | 576 |
No. of image planes | 47 | 47 |
Crystal size (mm) | 4.7 × 6.3 × 30 | 4.2 × 6.3 × 25 |
Crystal array per block | 8 × 6 | 9 × 6 |
Scintillator material | BGO | LYSO |
Coincidence window (nsec) | 9.5 | 4.9 |
FDG PET-CT Imaging Protocol
Standardized PET/CT Imaging Protocol
The non-enhanced low-dose CT part of the combined scan was acquired with a tube voltage of 120 kV, a tube current of 40 mA, and a tube rotation time of 0.5 s. The imaging range was from the vertex to the upper thighs. Consecutively, the emission PET data acquisition started with an acquisition time of 2 min per bed position. The CT data was used for attenuation correction. CT images were later reconstructed with 3.75-mm slice width, using a fully 3D iterative algorithm (ordered subset expectation maximization (OSEM)). For image post-processing, co-registration, and analysis, the reconstructed images were transferred to a commercially available computer workstation (Advantage Workstation 4.4, GE Healthcare).
Assessing Brown Adipose Tissue Activity
PET/CT Imaging of PSMA in Oncology
18F-DCFPyL was synthesized according to a previously published method (13 (link)). The administered activity was scaled by body weight (range, 237–474 MBq), allowing a 10% variation in target activity. After a 4-h fast, participants were injected intravenously with 18F-DCFPyL. Vital signs were measured before injection, 5–15 min afterward, and after the uptake phase. The subjects could eat between the radiotracer injection and the scan. After a 120-min uptake period, patients were imaged from top of head to mid thigh on a Discovery PET/CT 600 or 690 (GE Healthcare). A CT scan for localization and attenuation correction (120 kV, automatic milliamperage selection [range, 30–200 mA], and noise index of 20) was acquired. PET data were acquired immediately after the CT data over 2–4 min/bed position, adjusted for participant girth, and reconstructed with ordered-subset expectation maximization and point-spread-function modeling.
FDG-PET Imaging for Cardiac Sarcoidosis
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!